GDME1031FPR Coronary Stents ¢â‚¬â€œ Current and Coronary...

download GDME1031FPR Coronary Stents ¢â‚¬â€œ Current and Coronary Stents ¢â‚¬â€œ Current and Future Players 2 ¢© GlobalData

of 16

  • date post

    20-Jun-2020
  • Category

    Documents

  • view

    1
  • download

    0

Embed Size (px)

Transcript of GDME1031FPR Coronary Stents ¢â‚¬â€œ Current and Coronary...

  • REFERENCE CODE GDME1031FPR | PUBLICATION DATE NOVEMBER 2014

    CORONARY STENTS – CURRENT AND FUTURE PLAYERS

  • Coronary Stents – Current and Future Players 2 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.

    Table of Contents

    CORONARY STENTS – CURRENT AND FUTURE PLAYERS

    1 Table of Contents

    1 Table of Contents ....................................................................................................................... 2

    1.1 List of Tables ...................................................................................................................... 6

    1.2 List of Figures ................................................................................................................... 12

    2 Introduction ............................................................................................................................... 13

    2.1 Catalyst ............................................................................................................................. 14

    2.2 Related Reports ................................................................................................................ 15

    3 Competitive Assessment .......................................................................................................... 16

    3.1 Overview ........................................................................................................................... 16

    3.2 Trends in Coronary Stent Technology Development ......................................................... 17

    3.2.1 Development of Bare Metal Stents ................................................................................ 17

    3.2.2 Development of Drug-Eluting Stents ............................................................................. 19

    3.2.3 Development of Bioabsorbable Stents........................................................................... 22

    3.2.4 Development of Covered Stents .................................................................................... 23

    3.2.5 Coronary Stent Technology SWOT Analysis ................................................................. 24

    4 Pipeline Products ...................................................................................................................... 25

    4.1 Overview ........................................................................................................................... 25

    4.2 Pipeline by Stage of Development .................................................................................... 25

    4.3 Pipeline Product Profiles ................................................................................................... 28

    4.3.1 Bioabsorbable Stents .................................................................................................... 28

    4.3.2 Other Types of Vascular Stents ..................................................................................... 39

    5 Current and Future Players ....................................................................................................... 45

  • Coronary Stents – Current and Future Players 3 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.

    Table of Contents

    CORONARY STENTS – CURRENT AND FUTURE PLAYERS

    5.1 Overview ........................................................................................................................... 45

    5.2 Trends in Corporate Strategy ............................................................................................ 45

    5.3 Company Profiles .............................................................................................................. 48

    5.3.1 Abbott Vascular ............................................................................................................. 48

    5.3.2 Boston Scientific Corporation ........................................................................................ 54

    5.3.3 Medtronic ...................................................................................................................... 60

    5.3.4 Alvimedica ..................................................................................................................... 66

    5.3.5 Amaranth Medical ......................................................................................................... 70

    5.3.6 amg International .......................................................................................................... 73

    5.3.7 Arterial Remodeling Technologies ................................................................................. 77

    5.3.8 B. Braun ........................................................................................................................ 80

    5.3.9 Balton ............................................................................................................................ 83

    5.3.10 Biosensors International ................................................................................................ 88

    5.3.11 Biotronik ........................................................................................................................ 92

    5.3.12 Blue Medical.................................................................................................................. 97

    5.3.13 Cardionovum ............................................................................................................... 101

    5.3.14 C.R. Bard .................................................................................................................... 105

    5.3.15 Elixir Medical Corporation............................................................................................ 109

    5.3.16 eucatech AG ............................................................................................................... 114

    5.3.17 Hexacath ..................................................................................................................... 118

    5.3.18 IRAMED ...................................................................................................................... 121

    5.3.19 JW Medical Systems ................................................................................................... 124

    5.3.20 Kyoto Medical Planning ............................................................................................... 127

  • Coronary Stents – Current and Future Players 4 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.

    Table of Contents

    CORONARY STENTS – CURRENT AND FUTURE PLAYERS

    5.3.21 Lepu Medical Technology............................................................................................ 130

    5.3.22 MicroPort Scientific Corporation .................................................................................. 134

    5.3.23 Minvasys ..................................................................................................................... 138

    5.3.24 MIV Therapeutics ........................................................................................................ 142

    5.3.25 Opto Circuits ............................................................................................................... 146

    5.3.26 OrbusNeich Medical .................................................................................................... 150

    5.3.27 Relisys Medical Devices .............................................................................................. 154

    5.3.28 REVA Medical ............................................................................................................. 158

    5.3.29 Sahajanand Medical Technologies .............................................................................. 161

    5.3.30 STENTYS ................................................................................................................... 165

    5.3.31 Terumo Corporation .................................................................................................... 169

    5.3.32 Translumina ................................................................................................................ 173

    5.3.33 Vascular Concepts ...................................................................................................... 176

    5.3.34 Other Companies ........................................................................................................ 180

    6 Appendix................................................................................................................................. 192

    6.1 Bibliography .................................................................................................................... 192

    6.2 Abbreviations .................................................................................................................. 216

    6.3 Report Methodology ........................................................................................................ 223

    6.3.1 Overview ..................................................................................................................... 223